1、Prescription for Change:Policy Recommendations for Womens Health ResearchW H I T E P A P E RM A Y 2 0 2 5In collaboration with the Global Alliance for Womens Health,Kearney and the Gates FoundationImages:Midjourney,Getty ImagesDisclaimer This document is published by the World Economic Forum as a co

2、ntribution to a project,insight area or interaction.The findings,interpretations and conclusions expressed herein are a result of a collaborative process facilitated and endorsed by the World Economic Forum but whose results do not necessarily represent the views of the World Economic Forum,nor the

3、entirety of its Members,Partners or other stakeholders.2025 World Economic Forum.All rights reserved.No part of this publication may be reproduced or transmitted in any form or by any means,including photocopying and recording,or by any information storage and retrieval system.ContentsForewordExecut

4、ive summaryIntroduction:The case for womens health policy transformation1 Unlock innovation in womens health1.1 Womens health is underfunded and under-researched1.2 Success in orphan and paediatric diseases:Incentives drive investment and innovation1.3 Policy recommendations to unlock innovation in

5、womens health2 Expand the inclusion of women in clinical trials2.1 Women remain under-represented in clinical trials2.2 Success in paediatrics:Requirements and incentives drive inclusion2.3 Recent guidelines and initiatives start to focus on inclusion2.4 Policy recommendations to expand the inclusio

6、n of women in clinical trials3 Enhance disaggregation of clinical trial data3.1 Policy recommendations to enhance disaggregation of clinical trial data4 Design clinical trials with women in mind4.1 Policy recommendations to design clinical trials with women in mind5 Deepen insights into sex-specific